Drug trials often overlook pediatric patients, study shows

04/30/2012 | International Business Times

U.S. researchers looked at almost 2,500 drug trials from 2006 to 2011 and found only 12% targeted pediatric patients despite children representing 60% of the disease burden. They also reported that pediatric trials were often single-center rather than multicenter and that many failed to adequately examine safety outcomes. The study was presented at a Pediatric Academic Societies meeting and will be published in the journal Pediatrics.

View Full Article in:

International Business Times

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX